Treatment recommendation: To treat moderate to severely active ulcerative colitis a final guidance was published recommending vedolizumab (Entyvio, Takeda) Vedolizumab provides a further treatment option when conventional therapy or TNF-alpha inhibitors either don’t work well, has stopped working or can’t be tolerated. Vedolizumab is recommended on basis it is provided to the NHS at a…
Ngos Resign from Health Forum
PRESS RELEASE European Public Health Alliance – working Towards Better Health For All. Ngos resign from health forum as Commission ignores member state and European Parliament calls for alcohol strategy. Public Health NGOs have today resigned from the EU Alcohol and Health Forum, after Commissioner Andriukaitis said he has no plans to establish a new…
uk: Consultation on draft menopause guideline
Consultation on draft menopause guideline NICE (Monday 1 June) opened a public consultation on a draft clinical guideline about diagnosis and management of menopause. Menopause is when a woman stops having menstrual periods as she is reaching the end of her natural reproductive life. The drop in the level of oestrogen, the sex hormone, can…
uk: New drug availability
Various chronic diseases New drugs available on the NHS for chronic lymphocytic leukaemia. NICE has issued two pieces of final guidance recommending obinutuzumab …. more (Gazyvaro, Roche) and ofatumumab .…more (Arzerra, Novartis), which are each given in combination with chlorambucil, for people with previously untreated chronic lymphocytic leukaemia if treatments containing fludarabine or bendamustine are…
ie: Review on health effects of community water fluoridation
HRB publishes review on health effects of community water fluoridation No definitive evidence that community water fluoridation has negative health effects. The Health Research Board(HRB) published an in-depth evidence review of existing research in relation to the health effects of community water fluoridation. The HRB has found no definitive evidence that community water fluoridation is…
uk: Two eye treatments for serious diabetic eye conditions
Two eye treatments for serious diabetic eye condition – final draft guidance NICE recommended aflibercept solution for injection (Eylea, Bayer Pharma), and dexamethasone intravitreal(i) implant (Ozurdex, Allergan) as possible treatment options for some people with diabetic macular oedema, in two separate pieces of final draft guidance published (2 June). This oedema is a common complication…
eu: Endocrine disruptors, identification and related impacts
Event European Food Safety Authority (EFSA) Conference – “Endocrine disruptors: criteria for identification and related impacts”, 1 June 2015, Brussels The conference will inform Member States, Members of the European Parliament, third country representatives and stakeholders about the on-going impact assessment on criteria to identify endocrine disruptors and to provide a platform for further exchanges…
uk: Consultation on treatments for spinal arthritis
Consultation on draft guidance recommending treatments for types of arthritis that affecting spine NICE has today published draft guidance on adalimumab (Humira, AbbVie), etanercept (Enbrel, Pfizer), infliximab (Remicade, Merck Sharp & Dohme; Inflectra, Hospira; Remsima, Celltrion), certolizumab pegol (Cimzia, UCB Pharma) and golimumab (Simponi, Merck Sharp & Dohme) – known as TNF-alpha inhibitors – for…
uk: Device avoids surgery for enlarged prostate
Plans to support device that avoids surgery for enlarged prostate glands. A new device to relieve urinary tract problems caused by enlarged prostate glands in men is the focus of NICE draft guidance that opens for consultation (Friday 29 May 2015). Views on its draft medical technology guidance – provisionally recommending the UroLift system for treating…
Codeine restriction with children under 12 years old
Codeine not to be used for coughs and colds in children under 12 The Coordination Group for Mutual Recognition and Decentralised Procedures – Human (CMDh)1 agreed by consensus new measures to minimise the risk of serious side effects, including breathing problems, with codeine-containing medicines when used for cough and cold in children. As a result…